REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Aveflor, A.S. (Czech Republic)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Aveflor, A.S. Profile Updated: March 04, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Aveflor, A.S is a company specializing in the production of fire spray. It targets the Scandinavian markets and operates within the fire protection industry.

Headquarters
Budceves 26
Budceves; Kralovehradecky; Postal Code: 50732

Contact Details: Purchase the Aveflor, A.S. report to view the information.

Website: http://www.aveflor.cz

Basic Information
Total Employees:
Purchase the Aveflor, A.S. report to view the information.
Registered Capital:
Purchase the Aveflor, A.S. report to view the information.
Financial Auditors:
Purchase the Aveflor, A.S. report to view the information.
Incorporation Date:
September 14, 1995
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Vice Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Subsidiaries
AVEGUARD a.s.
50%
Company Performance
Financial values in the chart are available after Aveflor, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
28.51%▲
Total operating revenue
17.64%▲
Operating Profit/Loss (EBIT)
222.34%▲
EBITDA
117.69%▲
Net Profit/Loss for the Period
205.53%▲
Total Assets
-0.21%▼
Total Equity
14.14%▲
Operating Profit Margin (ROS)
4.94%▲
Net Profit Margin
3.34%▲
Return on Equity (ROE)
9.55%▲
Debt/Equity
-10.5%▼
Quick Ratio
0.35%▲

Similar companies

Molnlycke Health Care Procedurepak S.R.O.
 
Glenmark Pharmaceuticals S.R.O.
Bioveta, A.S.
 
Ferring-Leciva, A.S.
Synthon, S.R.O.
 
Sanaplasma S.R.O.
Exbio Praha, A.S.
 
Biopharm, Vyzkumny Ustav Biofarmacie A Veterinarnich Leciv A.S.
Interpharma Praha, A.S.
 
Steriwund Spol. S R.O.
Sct Cell Manufacturing S.R.O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo